Physician profile
Catherine Batton
NPI 1760830772
$3,092.32
in general payments reported to CMS, 2019-2025
12 companies · $905 in 2025
The $905 reported for 2025 was more than what 89% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $81.13 · 2020: $210 · 2021: $324 · 2022: $199 · 2023: $986 · 2024: $388 · 2025: $905.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,188 · Entertainment: $90.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,187.67 |
| Entertainment | $90.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $845.43 | 2023-2025 | Total30, Precision7, Dailies Total1 |
| Coopervision INC. | $702.95 | 2019-2025 | Cvi Contact Lens, Myday Contact Lens, Biofinity Contact Lens |
| Optos, INC. | $316.40 | 2020-2024 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Bausch & Lomb Americas INC. | $249.73 | 2022-2025 | Xiidra, Miebo, Infuse |
| Harrow Eye, LLC | $178.48 | 2025 | Vevye |
| Johnson & Johnson Vision Care, INC. | $162.97 | 2019-2021 | |
| Mallinckrodt Hospital Products INC. | $135.31 | 2022 | |
| Lkc Technologies, INC. | $127.34 | 2024 | |
| Tarsus Pharmaceuticals, INC. | $124.94 | 2025 | Xdemvy |
| Sun Pharmaceutical Industries INC. | $117.22 | 2019-2024 | |
| Rxsight INC | $115.38 | 2025 | Light Adjustable Lens (Lal), Rxsight Contact Lens, Rxsight Injector Cartridge |
| Biotissue Holdings INC. | $16.17 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Catherine Batton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.